Analyst Ratings February 12, 2026

Barclays Lifts McDonald’s Price Target to $380 After Strong Q4 Results

Firm keeps Overweight rating as comparable-sales momentum and unit growth underpin outlook; shares dip after hours on growth concerns

By Sofia Navarro MCD
Barclays Lifts McDonald’s Price Target to $380 After Strong Q4 Results
MCD

Barclays raised its price target on McDonald’s to $380 from $372 and maintained an Overweight rating following the company’s better-than-expected fourth-quarter 2025 comparable-sales and earnings results. Analysts have revised earnings estimates higher, while the stock traded near its 52-week high before slipping in after-hours trade amid investor questions about future growth.

Key Points

  • Barclays raised its McDonald’s price target to $380 from $372 and kept an Overweight rating.
  • McDonald’s beat expectations in Q4 2025 with adjusted EPS of $3.12 and revenue of $7.01 billion; U.S. comparable sales and positive guest counts supported the results.
  • Analysts revised earnings estimates upward, with 15 analysts lifting forecasts and targets ranging from $260 to $380; BMO Capital reiterated an Outperform rating and a $360 price target.

Barclays has increased its price target for McDonald’s (NYSE:MCD) to $380.00 from $372.00 while retaining an Overweight rating on the shares. At the time of the update, McDonald’s was trading at $323.21, roughly 1% below its 52-week high of $328.06, and had a market capitalization of $230.2 billion.

The boost to Barclays’ target followed McDonald’s fourth-quarter 2025 performance, where comparable sales outperformed Street expectations across all geographic segments and helped produce earnings-per-share upside. Barclays highlighted that U.S. comparable sales gained momentum through the fourth quarter of 2025 and that this positive trend has carried into the first quarter of 2026.

The firm pointed to McDonald’s strong top-line showing, attributing it to value-oriented product offerings and accelerating unit growth as central drivers behind the upward revision to the price objective. In its commentary, Barclays suggested that, amid uncertain global macroeconomic conditions, McDonald’s merits consideration as a defensive consumer staple play.

Market analysts broadly adjusted their forecasts following the quarter. According to available analyst revisions, 15 analysts raised their earnings estimates for the upcoming period, with target figures ranging between $260 and $380.

McDonald’s reported fourth-quarter 2025 adjusted earnings per share of $3.12, topping the consensus estimate of $3.04. Revenue for the quarter reached $7.01 billion, exceeding the anticipated $6.81 billion. The company’s revenue and earnings outperformance was driven by robust global comparable sales, with the U.S. notably contributing through positive guest counts.

Despite the stronger-than-expected results and analyst upward revisions, McDonald’s shares fell in after-hours trading as investors weighed concerns about the company’s trajectory for future growth.

Other broker activity included BMO Capital, which reiterated an Outperform rating on McDonald’s and maintained a price target of $360.00, reflecting continued confidence in the company’s earnings and revenue strength.


These developments give investors additional data points on McDonald’s recent financial performance, sell-side sentiment and the market reaction to reported results and forward-looking commentary.

Risks

  • Investor concerns about McDonald’s future growth prospects - reflected in the stock’s after-hours decline - could affect near-term sentiment in the consumer discretionary and consumer staples sectors.
  • Uncertain global macroeconomic conditions cited by Barclays may create downside pressure on restaurant industry demand and unit growth assumptions.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026